San Diego-based Therapeutics Company Announces $100M Private Placement
Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity.
The biopharmaceutical industry is a rapidly evolving space, with companies constantly seeking funds to fuel their innovative efforts. One such company making headlines is Regulus Therapeutics Inc. (NASDAQ: RGLS). The San Diego-based company recently announced an oversubscribed private placement of equity, raising a remarkable $100 million. $Regulus Therapeutics(RGLS.US$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
